Aura Biosciences, Inc. AURA Non Cash Lease Expense
Non Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept aura:NonCashLeaseExpense.
The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s non cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s non cash lease expense?
- Aura Biosciences, Inc. (AURA) reported non cash lease expense of $412K in Q1 2026.
- How has Aura Biosciences, Inc.'s non cash lease expense changed year-over-year?
- Aura Biosciences, Inc.'s non cash lease expense increased by 10.2% year-over-year, from $374K to $412K.
- What is the long-term trend for Aura Biosciences, Inc.'s non cash lease expense?
- Over 2 years (2023 to 2025), Aura Biosciences, Inc.'s non cash lease expense has grown at a -8.1% compound annual growth rate (CAGR), from $1.84M to $1.55M.
- What does non cash lease expense mean?
- Reflects the portion of lease expenses recognized in the income statement that does not result in an immediate cash outflow, typically associated with the amortization of right-of-use assets. This adjustment is necessary to reconcile net income to operating cash flow under standard accounting practices for lease obligations. It provides insight into the non-cash impact of long-term rental commitments on the company's financial results.